Costs of illness and care in Parkinson's disease: an evaluation in six countries

Eur Neuropsychopharmacol. 2011 Feb;21(2):180-91. doi: 10.1016/j.euroneuro.2010.08.002.


We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ambulatory Care / economics*
  • Antiparkinson Agents / economics*
  • Antiparkinson Agents / therapeutic use
  • Cost of Illness*
  • Europe
  • Female
  • Health Care Costs / statistics & numerical data
  • Hospitalization / economics*
  • Humans
  • Long-Term Care / economics*
  • Male
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / economics*
  • Surveys and Questionnaires


  • Antiparkinson Agents